Tempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 20,000 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $50.04, for a total value of $1,000,800.00. Following the completion of the sale, the chief executive officer owned 123,945 shares of the company’s stock, valued at $6,202,207.80. The trade was a 13.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The stock was sold at an average price of $46.19, for a total transaction of $1,100,153.42.
• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00.
• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The shares were sold at an average price of $44.07, for a total transaction of $597,148.50.

Tempus AI Stock Up 1.1%

Shares of TEM traded up $0.63 during mid-day trading on Tuesday, hitting $55.69. The company’s stock had a trading volume of 3,770,004 shares, compared to its average volume of 5,831,829. The company’s 50-day moving average is $51.37 and its 200-day moving average is $51.74. Tempus AI, Inc. has a 52-week low of $40.77 and a 52-week high of $104.32. The firm has a market capitalization of $10.05 billion, a price-to-earnings ratio of -38.67 and a beta of 3.58. The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to analyst estimates of $379.69 million. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. Tempus AI’s revenue was up 21.6% compared to the same quarter last year. During the same period last year, the company posted ($0.22) earnings per share. On average, equities research analysts forecast that Tempus AI, Inc. will post -1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. TD Cowen reissued a “buy” rating on shares of Tempus AI in a research report on Wednesday, July 15th. Stifel Nicolaus dropped their price objective on Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday, August 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tempus AI in a research note on Wednesday, June 17th. Guggenheim boosted their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Finally, Jefferies Financial Group assumed coverage on shares of Tempus AI in a research report on Monday, April 13th. They set an “underperform” rating and a $35.00 price target for the company. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $64.92.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPL Wealth Management LLC acquired a new stake in Tempus AI in the third quarter worth about $26,000. Los Angeles Capital Management LLC acquired a new position in shares of Tempus AI during the fourth quarter valued at about $27,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Tempus AI in the 3rd quarter valued at approximately $38,000. Danske Bank A S purchased a new position in shares of Tempus AI in the 3rd quarter valued at approximately $48,000. Finally, Sunbelt Securities Inc. acquired a new stake in Tempus AI in the 3rd quarter worth approximately $52,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.